Plan to scale back Medicare’s protected drug classes would hurt epilepsy patients

By , Guest Columnist Published: February 27, 2019 6:12 PM CT
Guest Columnist

Elisa Hertzan

Doctors need the discretion to choose the anticonvulsant drugs most effective at controlling seizures of epileptic patients. Changes proposed by the Centers for Medicare and Medicaid Services could exclude certain drugs from coverage.

Topics

Centers for Medicare and Medicaid Services Epilepsy Medicare Part D

Comments

Reading comments and joining the conversation are some of the many benefits of subscribing. Join the conversation by clicking the View Comments button below. Not a subscriber? Click here. 

Our commenting policy can be viewed here